Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system - Cao, Jinming; Chen, Zhicong; Wang, Yan; Ma, Yunpeng; Yang, Zhen; Cai, Jian; Xiao, Zhijun; Xu, Feng (Frontiers in Pharmacology, 2025)